Corcept Therapeutics, Inc. (CORT) Tops Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $114.86 +2.73%
Revenue Growth %: +54.6%
Financial Fact:
Research and development: 7.05M
Today's EPS Names:
ALZN, ASPU, USAU, More
Revenue Growth %: +54.6%
Financial Fact:
Research and development: 7.05M
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
Corcept Therapeutics, Inc. (NASDAQ: CORT) reported Q3 EPS of ($0.08), $0.01 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $1.05 million versus the consensus estimate of $2.07 million.
For earnings history and earnings-related data on Corcept Therapeutics, Inc. (CORT) click here.
For earnings history and earnings-related data on Corcept Therapeutics, Inc. (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McDonald’s said to plan value strategy overhaul to revive US sales growth
- Analysts eye Intuit investor day for signs estimates have troughed
- Piper Sandler Reiterates Overweight Rating on Block Inc. (XYZ)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
